Literature DB >> 1951417

Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism.

A N Hollenberg1, A Arnold.   

Abstract

The diagnosis of primary hyperparathyroidism has rested on the finding of hypercalcemia coupled with an elevated serum parathyroid hormone (PTH) level. Over 300 consecutive patients with primary hyperparathyroidism have had elevated or high-normal serum PTH levels using a specific immunoradiometric assay. Here we present a patient who proved to have surgically documented primary hyperparathyroidism in whom PTH levels were completely normal in all assays used. In the immunoradiometric assay, his normal result was unprecedentedly low (17 to 28 pg/mL; normal, 10 to 60 pg/mL) for this condition, and in a range consistent with non-PTH-dependent hypercalcemia or familial hypocalciuric hypercalcemia. This rare biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951417     DOI: 10.1016/0002-9343(91)90193-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism.

Authors:  J C Souberbielle; P Boudou; C Cormier
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 2.  Mild primary hyperparathyroidism: a literature review.

Authors:  Megan K Applewhite; David F Schneider
Journal:  Oncologist       Date:  2014-07-25

3.  Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl.

Authors:  Amanda D Benaderet; Amy M Burton; Roderick Clifton-Bligh; Ambika P Ashraf
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

4.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

5.  Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism.

Authors:  David F Schneider; Jocelyn F Burke; Kristin A Ojomo; Nicholas Clark; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-08-14       Impact factor: 5.344

6.  Standardisation of a two-site PTH immunoradiometric assay using various solid phase formats.

Authors:  U V Prasad; R Krishna Mohan; G Samuel; C V Harinarayan; N Sivaprasad; M Venkatesh
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

7.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

8.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

9.  Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.

Authors:  Angela Gurrado; Andrea Marzullo; Germana Lissidini; Agostino Lippolis; Domenico Rubini; Gaetano Lastilla; Mario Testini
Journal:  World J Surg Oncol       Date:  2008-02-21       Impact factor: 2.754

10.  Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism.

Authors:  Bruno Madeo; Elda Kara; Katia Cioni; Silvia Vezzani; Tommaso Trenti; Daniele Santi; Manuela Simoni; Vincenzo Rochira
Journal:  JBMR Plus       Date:  2017-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.